Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma.

Yang XY, Zhang D, Zou QF, Fan F, Shen F.

Med Oncol. 2013;30(3):593. doi: 10.1007/s12032-013-0593-9. Epub 2013 Jun 22.

PMID:
23794251
2.

Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma.

Ooi LP, Crawford DH, Gotley DC, Clouston AD, Strong RW, Gobe GC, Halliday JW, Bridle KR, Ramm GA.

J Hepatol. 1997 Apr;26(4):798-807.

PMID:
9126792
3.

Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.

Mazzocca A, Dituri F, Lupo L, Quaranta M, Antonaci S, Giannelli G.

Hepatology. 2011 Sep 2;54(3):920-30. doi: 10.1002/hep.24485. Epub 2011 Aug 8.

PMID:
21674557
4.

Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.

Santamato A, Fransvea E, Dituri F, Caligiuri A, Quaranta M, Niimi T, Pinzani M, Antonaci S, Giannelli G.

Clin Sci (Lond). 2011 Aug;121(4):159-68. doi: 10.1042/CS20110002.

PMID:
21413933
5.

[Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].

Wu XH, Wang SX, Yang YJ, Li JK, Xu Z, Tang RF.

Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):358-62. Chinese.

PMID:
21875465
6.

Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.

Wang WQ, Liu L, Xu HX, Luo GP, Chen T, Wu CT, Xu YF, Xu J, Liu C, Zhang B, Long J, Tang ZY, Yu XJ.

PLoS One. 2013 Aug 5;8(8):e71189. doi: 10.1371/journal.pone.0071189. Print 2013.

8.

Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma.

Mano Y, Aishima S, Fujita N, Tanaka Y, Kubo Y, Motomura T, Taketomi A, Shirabe K, Maehara Y, Oda Y.

Pathobiology. 2013;80(3):146-54. doi: 10.1159/000346196. Epub 2013 Jan 25.

PMID:
23364389
9.

Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma.

Zhou L, Wang Y, Tian DA, Yang J, Yang YZ.

Mol Med Rep. 2012 Dec;6(6):1261-6. doi: 10.3892/mmr.2012.1096. Epub 2012 Sep 24.

PMID:
23007408
10.

High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.

Zhang Y, Tan YF, Jiang C, Zhang K, Zha TZ, Zhang M.

Pathol Oncol Res. 2013 Jan;19(1):79-88. doi: 10.1007/s12253-012-9560-6. Epub 2012 Sep 12.

PMID:
22965687
11.

Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC.

PLoS One. 2011;6(10):e26608. doi: 10.1371/journal.pone.0026608. Epub 2011 Oct 19.

12.

Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.

Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, Aquino JB, Fiore E, Rizzo MM, Rodriguez A, Lorenti A, Andriani O, Podhajcer O, Mazzolini G.

Mol Pharm. 2011 Oct 3;8(5):1538-48. doi: 10.1021/mp200137c. Epub 2011 Aug 19.

PMID:
21770423
13.

[The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].

Liu Y, Chen X, Peng S, Fang H, Wu Y, Peng C, Shi L, Bai M, Xu B, Wang J, Deng G.

Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1553-6. Chinese.

PMID:
12609066
14.

Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.

Gao J, Ding F, Liu Q, Yao Y.

Mol Cell Biochem. 2013 Apr;376(1-2):21-32. doi: 10.1007/s11010-012-1545-y. Epub 2012 Dec 12.

PMID:
23232575
15.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
16.

Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.

Yau WL, Lam CS, Ng L, Chow AK, Chan ST, Chan JY, Wo JY, Ng KT, Man K, Poon RT, Pang RW.

PLoS One. 2013;8(3):e57882. doi: 10.1371/journal.pone.0057882. Epub 2013 Mar 6.

17.

Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma.

Liao R, Sun TW, Yi Y, Wu H, Li YW, Wang JX, Zhou J, Shi YH, Cheng YF, Qiu SJ, Fan J.

Cancer Sci. 2012 Jun;103(6):984-92. doi: 10.1111/j.1349-7006.2012.02273.x. Epub 2012 Apr 19.

18.

LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.

Wang H, Li W, Jin X, Cui S, Zhao L.

Eur J Cancer. 2013 Mar;49(4):974-83. doi: 10.1016/j.ejca.2012.09.032. Epub 2012 Oct 18.

PMID:
23084841
19.

Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.

Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.

J Gastroenterol Hepatol. 2012 Jan;27(1):173-80. doi: 10.1111/j.1440-1746.2011.06847.x.

PMID:
21777276
20.

Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis.

Zhou Q, Huang T, Wang YF, Zhou XB, Liang LJ, Peng BG.

Chin Med J (Engl). 2011 Nov;124(22):3746-51.

PMID:
22340235

Supplemental Content

Support Center